← Leaderboards
Harvinder Singh Gill
Texas Tech University
$13,125,823
Attributed
$13,125,823
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.5M · FY2011–25$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,125,823 · 8
By mechanism
R01$9,776,801 · 4
DP2$2,205,000 · 1
R56$584,330 · 1
R21$347,684 · 1
R03$212,008 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Antigens”
- Barton F Haynes · Duke University$488,918,563
- Lawrence Corey · Fred Hutchinson Cancer Center$325,880,100
- Dennis R. Burton · Scripps Research Institute$291,395,948
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$245,204,950
- Jeffrey P Krischer · University Of South Florida$208,289,343
- Dan H. Barouch · Fred Hutchinson Cancer Center$124,506,327
Research focus
AntigensChildBaseAntibodiesImmune ResponseDoseImmuneIn VivoInfluenzaInfluenza Virus VaccineImmunogenicityFamily SuidaeInfluenzavirusGillsMouse ModelDesignAllergen ImmunotherapyVaccinesClinicLangerhans CellSkinSurfaceHypersensitivitySafety
Grant awards (23)
Floss: a novel method for oral mucosal vaccination$568,634
R01 · FY2025 · DE · contact PI
Floss: a novel method for oral mucosal vaccination$601,354
R01 · FY2024 · DE · contact PI
Development of a Universal Influenza Vaccine Against Influenza A and B Viruses$668,028
R01 · FY2023 · AI · contact PI
Development of a Universal Influenza Vaccine Against Influenza A and B Viruses$687,398
R01 · FY2022 · AI · contact PI
Microneedles for treatment of peanut allergy$632,712
R01 · FY2022 · AI · contact PI
Development of a Universal Influenza Vaccine Against Influenza A and B Viruses$689,042
R01 · FY2021 · AI · contact PI
Microneedles for treatment of peanut allergy$649,847
R01 · FY2021 · AI · contact PI
Development of a Universal Influenza Vaccine Against Influenza A and B Viruses$703,942
R01 · FY2020 · AI · contact PI
Microneedles for treatment of peanut allergy$656,540
R01 · FY2020 · AI · contact PI
Microneedles for allergy immunotherapy$363,495
R01 · FY2020 · AI · contact PI
Development of a Universal Influenza Vaccine Against Influenza A and B Viruses$716,192
R01 · FY2019 · AI · contact PI
Microneedles for treatment of peanut allergy$656,407
R01 · FY2019 · AI · contact PI
Microneedles for allergy immunotherapy$360,853
R01 · FY2019 · AI · contact PI
Microneedles for treatment of peanut allergy$718,524
R01 · FY2018 · AI · contact PI
Microneedles for allergy immunotherapy$358,370
R01 · FY2018 · AI · contact PI
Engineering an intranasal universal influenza vaccine$584,330
R56 · FY2017 · AI · contact PI
Microneedles for allergy immunotherapy$391,822
R01 · FY2017 · AI · contact PI
Microneedles for allergy immunotherapy$353,641
R01 · FY2016 · AI · contact PI
Nanoengineered virus-mimics as templates for design of a universal influenza A va$132,587
R21 · FY2013 · AI · contact PI
POLLEN GRAINS AS TROJAN HORSES FOR ORAL VACCINATION$2,205,000
DP2 · FY2012 · HD · contact PI
Nanoengineered virus-mimics as templates for design of a universal influenza A va$215,097
R21 · FY2012 · AI · contact PI
Targeting the oral cavity epithelium for inducing mucosal immunity against HIV$106,077
R03 · FY2012 · DE · contact PI
Targeting the oral cavity epithelium for inducing mucosal immunity against HIV$105,931
R03 · FY2011 · DE · contact PI